Microneedling and FDA Clearance: What It Actually Means
Last updated: October 6, 2026
The short answer
No microneedling pen is FDA-cleared for home use. Every microneedling pen cleared by the U.S. Food and Drug Administration is cleared for prescription or professional use, usually for a specific indication such as facial acne scars. Pens sold directly to consumers for home use are not covered by those clearances, even when they share a brand name with a cleared model.
That doesn’t automatically make a home device dangerous, and a clearance doesn’t make a device risk-free. But you should know what “FDA cleared” means, and doesn’t mean, before you buy.
How the FDA regulates microneedling
Since 2018, the FDA has classified microneedling devices for aesthetic use as Class II medical devices under 21 CFR 878.4430 (product code QAI). Class II devices generally need a 510(k) clearance. That means the manufacturer shows the FDA its device is “substantially equivalent” to one already legally on the market. The first device in the category, the SkinPen Precision, went through the De Novo pathway (DEN160029) in 2018.
In November 2020 the FDA published its final guidance, Regulatory Considerations for Microneedling Products. It explains that a microneedling product can be a regulated medical device because of:
- what it claims to do, such as treating scars, wrinkles or acne marks, or stimulating collagen, or
- how it’s designed, for example needles long enough to penetrate living layers of skin.
In other words, a seller can’t avoid device status just by calling a pen “cosmetic” if its design does what a medical device does.
“Cleared”, “approved” and “registered”: decoding the claims
| What you see | What it actually means |
|---|---|
| FDA cleared | The specific model has a 510(k) or De Novo authorization for a specific use. You should be able to find it in the FDA database by name or K-number. |
| FDA approved | Usually wrong for microneedling pens. “Approval” (PMA) applies to higher-risk Class III devices. A pen marketed as “FDA approved” deserves a closer look. |
| Made in an FDA-registered facility | The factory is registered with the FDA. That is an administrative listing, not a review or clearance of the product. |
| FDA listed | The device is listed in the FDA’s registration database. That also isn’t a clearance. |
| Uses an FDA-cleared design | Not meaningful on its own. Clearance applies to a specific manufacturer’s specific device. |
Microneedling devices with FDA clearance (product code QAI)
These are taken from the FDA 510(k) and De Novo databases. Every one listed is for prescription or professional use.
| Device | Company | FDA number(s) | First cleared |
|---|---|---|---|
| SkinPen Precision / Precision Elite | Bellus Medical / Crown Aesthetics | DEN160029, K202243, K220506, K241400 | 2018 |
| Exceed / Exceed Unlimited | MT.DERM GmbH | K180778, K182407, K233709 | 2018 |
| Rejuvapen NXT | Refine USA | K192138 | 2020 |
| SkinStylus SteriLock | Esthetic Education / Esthetic Medical | K200044, K231073, K253002 | 2020 |
| Eclipse MicroPen EVO | Eclipse Medcorp | K203144, K212558 | 2021 |
| Collagen P.I.N. | Induction Therapies | K222199 | 2022 |
| AI.ME System | Venus Concept | K221011 | 2022 |
| DP4 Microneedling device (Dermapen 4)* | Equipmed USA | K221070 | 2022 |
| Dr. Pen A20 | Guangzhou Ekai Electronic Technology | K230420 | 2023 |
| SER Pen Carain | Su-Ko Technologies | K241355, K253153 | 2024 |
| XCellarisPRO TWIST | Dermaroller GmbH | K241790 | 2025 |
| 1NEED Pro | Campomats S.R.L. | K243472 | 2025 |
| E-PEN | Bomtech Electronics | K243143 | 2025 |
| PRO Pen (6883) | Dermalogica | K243800 | 2025 |
| CODE-X | Woorhi Mechatronics | K252591 | 2026 |
Also under QAI: Cytrellis ellacor (dermal micro-coring), K202517 and K252752. It’s a related but different technology.
*The FDA record names the device “DP4 Microneedling device” and never uses the name Dermapen. Its specifications (16 needles, 0.2–3 mm, a “DP4 US” companion app) match the Dermapen 4.
Check any device in our lookup table →
What a clearance covers and what it doesn’t
A clearance is narrower than most marketing suggests:
- One model from one manufacturer. The Dr. Pen A20 clearance (K230420) covers the A20. It doesn’t cover the M8, A6S, A11 or any other Dr. Pen model.
- Specific indications. Every clearance names what the device is for, and they differ. Most pens are cleared to improve the appearance of facial acne scars in adults aged 22 and over. The Rejuvapen NXT is cleared only for wrinkles around the eyes. The first Exceed clearance (K180778) covers frown lines, eye lines and cheek folds. The first SkinStylus clearance (K200044) covers surgical or traumatic hypertrophic scars on the abdomen. SkinPen’s 2021 clearance (K202243) added wrinkles of the neck, an indication its later clearances keep. None of the clearances in the table cover hair loss or stretch marks.
- Specific skin types. Many clearances are limited to Fitzpatrick skin types I–III or I–IV, the lighter skin types. Collagen P.I.N., for example, is cleared for types I–III. A few are not: SkinPen’s and the MicroPen EVO’s acne-scar indications cover all skin types, and the latest SkinStylus clearance (K253002) covers wrinkles around the eyes in skin types I–VI. If you have a deeper skin tone, check the indication before assuming a cleared device was tested on skin like yours.
- Prescription use. On every one of the 26 clearances filed under the FDA’s microneedling product code (QAI), the device’s Indications for Use form ticks “Prescription Use”. None ticks “Over-The-Counter Use”.
- The cleared configuration. Depth limits, cartridges and instructions are part of what was cleared. A retail version with a different depth range or different cartridges may not match.
- Rebranded pens. Some pens are made by a contract manufacturer and sold under a retailer’s brand, citing the manufacturer’s clearance. Whether that clearance covers the rebranded product depends on whether it’s the same device, sold for the same use, with the same labelling. Ask the seller for the K-number and compare.
Why uncleared pens are still widely sold
Most microneedling pens sold online, including many of the most popular home devices, have no FDA clearance. They remain available because:
- many are shipped from overseas directly to individual buyers. The FDA’s personal importation policy gives its staff discretion over small shipments for personal use. That discretion isn’t an authorization, and the FDA can refuse any shipment.
- some are marketed with cosmetic-only language, although the 2020 guidance says design can make a product a device whatever the marketing says
Being on sale doesn’t mean a device has been reviewed by any regulator. Our reviews report each device’s regulatory status so you can weigh it yourself.
Outside the United States
- Canada: On December 16, 2021, Health Canada issued an advisory that Dr. Pen microneedling devices were not authorized for sale in Canada and might pose health risks. It named models including the A1, A6, A6S, A7, E30, M5, M7, M8, N2 and X5, and the Ultima versions, and covered “all models”. The same advisory said that “to date, no microneedling devices have been authorized for at-home use”. Health Canada now lists that advisory as archived. Two Dr. Pen models, the A20 and A9, have held a Canadian licence since January 2026.
- Australia: Microneedling devices are regulated by the TGA and must be listed on the Australian Register of Therapeutic Goods (ARTG).
- European Union / UK: A microneedling device sold for a medical purpose needs CE marking in the EU. Great Britain accepts UKCA marking and, for now, CE marking too. Classification varies by device; Dermaroller GmbH states Class IIa for its medical rollers, a certificate issued under the older EU directive.
Read our international regulation guide →
How to check a device yourself
- Ask the seller for the K-number (it looks like K123456) or De Novo number.
- Search the FDA 510(k) database: go to accessdata.fda.gov and open the 510(k) Premarket Notification database. Search by K-number, device name or applicant.
- Check the details match: applicant, device name, model and indication. Open the PDF summary to see the depth range and intended use.
- Check for adverse event reports: search the FDA MAUDE database by brand name. Reports aren’t proof a device caused harm, but patterns are worth knowing about.
- In Canada, search Health Canada’s MDALL (Medical Devices Active Licence Listing) by company name or licence number as well as by brand, because a licence can be listed under a generic name: the current Dr. Pen licence is called “Microneedling System”. In Australia, search the ARTG.
If something goes wrong
If you have a serious reaction or injury after microneedling, see a doctor first. Then report it:
- United States: FDA MedWatch (Form 3500, online)
- Canada: Health Canada’s medical device problem reporting
- Australia: the TGA’s adverse event reporting
Reports help regulators spot problems with specific devices.
FAQ
Is any at-home microneedling pen FDA-cleared?
No. As of October 2026, every FDA-cleared microneedling pen is for prescription or professional use.
Is the Dr. Pen FDA-cleared?
One model is. The Dr. Pen A20 (K230420) is cleared for prescription use. Other Dr. Pen models are not covered by that clearance.
Are dermarollers FDA-cleared?
No consumer roller appears among the FDA’s microneedling clearances. The FDA’s 2020 guidance sets no needle-length cut-off: whether a roller is a regulated device depends on what the seller claims it does and whether its needles are designed to reach living layers of skin. See our derma roller guide.
Does FDA clearance mean a device is safe?
It means the FDA found the device substantially equivalent to a legally marketed device for a specific use, under specific conditions. Results and safety still depend on technique, hygiene and choosing a suitable depth.
What’s the difference between FDA cleared and FDA approved?
“Cleared” refers to the 510(k) or De Novo pathway used for Class II devices like microneedling pens. “Approved” refers to premarket approval (PMA) for Class III devices. A microneedling pen marketed as “FDA approved” is almost certainly using the wrong term.
Sources
- 21 CFR 878.4430, Microneedling device for aesthetic use
- FDA, Regulatory Considerations for Microneedling Products (final guidance, issued November 10, 2020): https://www.fda.gov/media/107708/download
- FDA 510(k) database, product code QAI: https://api.fda.gov/device/510k.json?search=product_code:QAI
- SkinPen De Novo DEN160029: https://www.accessdata.fda.gov/cdrh_docs/pdf16/DEN160029.pdf
- Dr. Pen A20 K230420: https://www.accessdata.fda.gov/cdrh_docs/pdf23/K230420.pdf
- Dermapen 4 (DP4) K221070: https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221070.pdf
- Health Canada advisory on Dr. Pen devices (December 16, 2021, now archived): https://recalls-rappels.canada.ca/en/alert-recall/dr-pen-microneedling-devices-are-not-authorized-sale-and-may-pose-health-risks
- Health Canada licence 114618 (Dr. Pen A20 and A9, from January 6, 2026): https://health-products.canada.ca/api/medical-devices/deviceidentifier/?licence_id=114618&lang=en&type=json
This article is for information only and is not medical or legal advice.